Apomorphine as a preferential stimulant of self-inhibitory dopamine receptors in man
- PMID: 756167
Apomorphine as a preferential stimulant of self-inhibitory dopamine receptors in man
Abstract
In man, non emetic doses of apomorphine elicit a series of behavioural, neurological and psychological changes which are difficult to ascribe to the stimulation of postsynaptic dopamine receptors. Since similar effects are elicited by neuroleptic drugs, the functional changes induced by apomorphine in man might be interpreted as being the result of a decreased dopaminergic activity. The sedation and sleep, the improvement of choreic movements and the antipsychotic effect induced by non emetic doses of apomorphine are prevented by specific dopamine receptor blockers. These responses therefore are mediated through a stimulation of dopamine receptors leading to a decreased dopaminergic transmission. This new type of receptors might be identified with the so called "self-inhibitory" dopamine receptors.
Similar articles
-
Self-inhibitory dopamine-receptors and central effects of apomorphine.Ann Ist Super Sanita. 1978;14(1):111-22. Ann Ist Super Sanita. 1978. PMID: 756166
-
Neuropsychiatric implications of drugs acting on dopamine receptors: the effect of apomorphine.Prog Clin Biol Res. 1980;39:225-37. Prog Clin Biol Res. 1980. PMID: 6447296 No abstract available.
-
Self-inhibitory dopamine receptors: their role in the biochemical and behavioral effects of low doses of apomorphine.Adv Biochem Psychopharmacol. 1978;19:275-92. Adv Biochem Psychopharmacol. 1978. PMID: 358782 Review. No abstract available.
-
Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.J Pharmacol Exp Ther. 1997 Jan;280(1):73-82. J Pharmacol Exp Ther. 1997. PMID: 8996184
-
Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?J Psychiatry Neurosci. 2001 May;26(3):203-20. J Psychiatry Neurosci. 2001. PMID: 11394190 Free PMC article. Review.